No description available.

In this work magnetic properties of copper(II) complexes on N-(hydroxyalkyl) pyrrole-2-aldimines were investigated by various techniques, one of which was magnetic susceptibility. Magnetic moments are not directly determined experimentally, but magnetic susceptibilities are.

Spectroscopic studies have been used to describe the mechanism of the decomposition of hydrogen peroxide by solutions of a dimeric Cu(II) complex of a dissymetric Schiff base, [CuSALAD]2.H2O, and imidazole or methyl substituted imidazoles, B, which form monomeric CuSALAD.B2 complexes, in aqueous ethanol solvent. Freezing point depression and vapor pressure lowering studies were carried out to confirm the dimeric nature of the [CuSALAD]2.H2O complex that had been previously reported. The stoichiometry of the [CuSALAD]2.H2O-imidazole equilibrium was extensively studied pointing to a 1:4 stoichiometry. The CuSALAD.B2 adducts exhibited certain catalytic properties that mimic those of catalase enzymes. The different imidazoles were buffered to acidic, neutral and basic pH media in order to investigate the pH effects of this reaction. Two charge transfer (CT) bands were observed near 420 and 450 nm upon addition of hydrogen peroxide to CuSALADB2 solutions, and were associated with two proposed intermediates (CuBOOH and CuBOOCu). A mechanism consistent with these results has been developed. First order dependence of the rate on CuSALAD.B2 was observed in the presence of excess CuSALAD.B2 over hydrogen peroxide, whereas second order dependence was observed with the latter in excess. The CuBOOCu intermediate was unstable in the presence of EDTA, and a first order dependence of rate of formation of intermediate on both CuSALAD.B2, and hydrogen peroxide was observed.

A series of dihydroxy bridged copper(II) complexes of the type [(L)Cu(OH)₂Cu(L)]x₂ * nH₂0, where L is 2,2'-bipyridine, 4,4'-dimethyl-2,2'-bipyridine or 1,10-phenanthroline, x is a counter ion, and n is the number of water molecules, was synthesized. In the case of monohydroxy bridged copper(II) complexes, we have found a new method of synthesis for [ (L)₂Cu(OH)Cu(L)₂ ] (ClO₄)₃, where L is 2,2'-bipyridine or 1,10-phenanthroline. We have synthesized five new monohydroxy bridged copper(II) complexes, thus increasing the number of monohydroxy bridged copper(II) complexes to nine. All complexes have been characterized by infrared spectroscopy, UV-visible spectroscopy, magnetic moments, and elemental analysis. The electron spin resonance results establish that the fulvic acids contain organic free radicals as an internal part of their molecular structure. The concentration of unpaired electrons will increase by increasing the pH. The unpaired electron in fulvic acid interacts with the unpaired electron on copper(II) through the Π system, and this will decrease the spin concentration of fulvic acid complexed with copper(II). The displacement of titration curve from a free ligand (fructose-1,6-diphosphate, ribulose-1,5-diphosphate, phospherine, phosphothreonine, and 3-phosphoglyceric acid, to a ligand plus copper(II) (1:1 ratio) shows there is a strong interaction between copper(II) and the corresponding ligand. All complexes absorb UV-visible at 250-300 nm. The absorption intensity changes as a function of pH. Copper (II) forms a complex with fructose-1,6-diphosphate, ribulose-1,5-diphosphate, phosphoserine, phosphothreonine, and 3-phosphoglyceric acid by the ratio of 1:3, 1:3, 1:1, 1:1, and 1:2, respectively.

Previous studies involving copper (II) complexed with a dissymmetric Schiff base and imidazole derivatives had identified catalase activity of these complexes towards H2O2. Reactions such as this are of great interest due to the important role of copper-based complexes in biological systems. Our research has been conducted to add to the base of knowledge regarding the efforts of other researchers to investigate copper complexes that exhibit similar reactivity as copper-based proteins towards dioxygen. The copper complex chosen for this study contained a tri-dentate Schiff base adduct which, when complexed with an imidazole derivative, limited the manner in which peroxo adducts could bind while providing distinct spectral peaks which were used to conduct kinetic studies. Our results indicate a reaction mechanism by which the role of the complexed copper (II) ion is to activate the peroxo adduct for decomposition through reactions with other peroxide molecules, dioxygen, and water.

Photo sensitizers showing visible light induced DNA cleavage activity are of current importance for medicinal applications related to photodynamic therapy (PTD) considering greater skin penetration of light near 700 nm. While organic molecules and complexes of 4d-5d metal ions are extensively studied for their DNA photo-damage properties in UV and visible light, the chemistry of 3D metal complexes showing visible light-induced DNA cleavage activity is relatively unexplored efforts have been made in this thesis work to design new ternary copper (II) complexes having a-amino acids Such copper (II) complexes with tunable coordination geometry could find potential applications in PDT. Ternary Copper (II) complexes containing L-methionine, S-methy1-L-cysteine and phenanthroline bases are prepared and characterized. They display DNA binding and visible light induced DNA cleavage activity. An enhancement of the DNA cleavage activity is observed for analogous ternary copper (II) complexes contained L-lysine with a pendant cationic amine moiety as a photo-induced DNA Cleavage activity using binary and ternary copper (II) complexes of L-arginine and phenanthroline bases. We have observed AT selective DNA binding and visible light –induced DNA cleavage activity. The crescent-shaped bis-arginine Copper (II) complex mimics the natural antiviral antibiotic netropsin. T o investigate the role of the pendant groups of the amino acids, we have explored the DNA binding and DNA cleavage activity of analogues L-glutamine and L-asparagine complexes. We have prepared ternary copper (II) complexes containing two photosensitizers, viz., L-tryptophan (L-trp) and dipyridoquininoxaline/dipyridophenazine to achieve double strand breaks forming linear DNA. Complex [Cu(L-trp)(dppz)(H2O)+ shows a stacking arrangement of the indole and dppz rings giving a separation that fits with the base pair separation of ds-DNA. Photosensitizes in these complexes approach two different complementary stands of the ds-DNA, leading to double strand breaks and formation of linear DNA. Mechanistic studies on the DNA photocleavage reactions reveal the formation of singlet oxygen(1O2)species by a type-II pathway in preference to the hydroxyl radical generation. A process leading to an efficient DNA cleavage activity on visible light irradiation. The observation of sequence selectivity and double strand DNA cleavage on red light exposure by national design of the complexes is significant considering importance of the results in the chemistry of photodynamic therapy of cancer. The results of this dissertation open up new avenues for designing and developing 3d metal-based photosensitizers with potential utility in nulcleic acid chemistry.

[pt] Foram sintetizados 16 complexos de cobre(II) coordenados com seis aminoácidos presentes na placa b-amilóide, que está associada à Doença de Alzheimer - ácido aspártico, ácido glutâmico, metionina, glicina, serina e arginina, outros dois aminoácidos também encontrados no cérebro - cisteína e homocisteína, além da L-carnitina e acetil-L-carnitina que vêm sendo utilizados como suplemento alimentar em pacientes com doenças neurodegenerativas. Nosso objetivo foi verificar a afinidade do cobre(II) com estes aminoácidos, uma vez que o envelhecimento provoca aumento no cérebro tanto das concentrações de íons cobre como dos níveis de todos estes aminoácidos (que são consequência de fragmentações peptídicas). Por esta razão, procurou-se trabalhar in vitro com condições próximas ao meio biológico utilizando apenas água deionizada como solvente. Os complexos obtidos foram caracterizados pelas seguintes técnicas: análise elementar (espectrometria de absorção atômica e CHN), condutimetria, análise termogravimétrica, ressonância paramagnética eletrônica, voltametria cíclica e espectroscopia no infravermelho. Foi possível verificar que, exceto a acetil-L-carnitina, todos se comportam como ligantes bidentados e complexam facilmente ao cobre(II). Ácido aspártico, ácido glutâmico, serina, metionina, glicina e arginina se coordenaram através do átomo de oxigênio do grupo carboxilato e do átomo de nitrogênio do grupo amino, cisteína e homocistéina através do átomo de enxofre e do átomo de nitrogênio do grupo amino, L-caritina através do átomo de oxigênio do grupo carboxilato e do átomo de oxigênio alcoólico e acetil-L-carnitina se coordena monodentadamente através do átomo de oxigênio do grupo carboxilato. / [en] Sixteen complexes of copper(II) with six amino acids that are present in the b-amyloid peptide, which is associated with Alzheimer’s disease - aspartic acid, glutamic acid, methionine, glycine, serine and arginine -, two amino acids also found in the brain - cysteine and homocysteine -, as well as L-carnitine and acetyl-L-carnitine, which have been used as food supplement in patients with neurodegenerative diseases, were studied. Our aim was to determine the affinity of copper(II) with these amino acids, since aging causes an increase in brain concentrations of copper ions as well as in the level of all of these amino acids, as a consequence of peptide fragmentation. For this reason, we decided to do an in vitro study in similar conditions as the biological environment, using only deionized water as solvent. These compounds were characterized through the following techniques: elementary analysis (atomic absorption spectrometry and CHN), conductimetry, thermogravimetric analysis, electron paramagnetic resonance, electrochemical analysis, and infrared spectroscopy. It was possible to verify that, except for acetyl-L-carnitine, all amino acids behaved as bidentate ligands. They all form complexes with copper(II) easily. Aspartic acid, glutamic acid, serine, methionine, glycine and arginine coordinate through the oxygen atom of the a-carboxylate group and the nitrogen atom of the amine group. Cysteine and homocysteine coordinate through the sulfur atom and the nitrogen atom of the amine group, L-Carnitine coordinates through one oxygen atom of the carboxylate group and one oxygen atom of the alcohol group, and acetyl-L -carnitine coordinates through the oxygen atom of the carboxylate group.

[pt] Este trabalho descreve a síntese e caracterização de quatro complexos de cobre (II) e quatro complexos de zinco (II), com dipeptídeos, no estado sólido. Os dipeptídeos envolvidos foram: glicil-glicina, glicil-valina, metionil-metionina, metionil-glicina e cisteinil-glicina, cujos aminoácidos fazem parte de algumas proteínas envolvidas em processos de neurodegeneração, mais especificamente na doença de Alzheimer. Embora os mecanismos que desencadeiam esta patologia não estejam ainda totalmente esclarecidos, sabe-se que os íons metálicos, como o cobre (II) e o zinco (II), interagem com o peptídeo beta-amilóide. Acredita-se que tais interações favoreçam a formação de agregados protéicos sólidos deste peptídeo, observados nos cérebros de pacientes com essa doença. Dessa forma, a obtenção e o estudo de modelos simples no estado sólido, sintetizados em condições próximas ao meio biológico, podem permitir uma melhor compreensão de possíveis interações de tais metais neste sítio protéico. Os compostos obtidos foram caracterizados utilizando as seguintes técnicas: análise elementar, absorção atômica, espectroscopia de infravermelho, espectroscopia Raman, espectroscopia de ultravioleta-visível, termogravimetria, RPE (para os complexos de cobre) e condutivimetria. Para os complexos de zinco, foram realizados cálculos teóricos mecânico-quânticos para obtenção de parâmetros geométricos e espectros de infravermelho. A análise dos compostos obtidos mostrou que os complexos de cobre e zinco com os dipeptídeos estão coordenados por átomos de oxigênio e nitrogênio. Nos complexos de peptídeos contendo enxofre, a coordenação também ocorre pelo átomo de enxofre (cobre com metionil-metionina e metionil-glicina e zinco com cisteinil-glicina). Os compostos obtidos para ambos os metais na proporção metal-ligante (1:1) mostram comportamento diferente dos estudos em solução e aqueles obtidos na proporção metal-ligante (1:2) mostram comportamento similar a complexos de metais com aminoácidos. / [en] This work describes the synthesis and characterization of copper (II) and zinc (II) complexes, with dipeptides in solid state. The dipeptides involved were: glycyl-glycine, glycyl-valine, methionyl-methionine, methionyl-glycine and cysteinyl-glycine, whose aminoacids take part in some proteins involved in neurodegeneration processes, more specifically in Alzheimer’s disease. Although the mechanisms that trigger this pathology are still not totally clear, it is known that metallic ions, such as copper (II) and zinc (II) interact with the beta-amyloid peptide. It seems that such interactions favor the formation of solid proteic aggregates of this peptide, observed in the brains of patients with Alzheimer’s disease. Thus, the obtaining and study of simple models in the solid state, synthesized in similar conditions to the biological medium, may allow a better understanding of the possible interactions of such metals in this proteic site. The compounds obtained were characterized using the following techniques: elemental analysis, atomic absorption, infrared spectroscopy, Raman spectroscopy, ultraviolet-visible spectroscopy, thermogravimetry, EPR (for the copper complexes) and conductivimetry. For the zinc complexes, quantum-mechanical theoretical calculations were performed to obtain geometrical parameters and infrared spectra. The analysis of the compounds showed that the copper and zinc complexes with dipeptides are coordinated through oxygen and nitrogen atoms. In complexes of dipeptides containing sulfur, coordination trough the sulfur atom occurs too (copper with methionyl-methionine and methionyl-glycine and zinc with cysteinyl-glycine). The compounds obtained for both metals at the metal-ligand ratio (1:1) behave differently from those studied in solution e those obtained in the metal-ligand ratio (1:2) show similar behavior of metal complexes with aminoacids.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / No presente trabalho é descrita a obtenção de hidrazonas derivadas de isoniazida e de seus complexos de cobre(II) e gálio(III) candidatos a protótipos de fármacos antituberculose e antitumoral. Para investigar o efeito da modificação química sobre as bioatividades do fármaco isoniazida, foram preparados cinco derivados hidrazônicos: 2-piridinocarboxaldeído isonicotinoil hidrazona (HPCIH, 1), 2-acetilpiridina isonicotinoil hidrazona (HAPIH, 2), 2-benzoilpiridina isonicotinoil hidrazona (HBPIH, 3), 2-piridinoformamida isonicotinoil hidrazona (HPAmIH, 4) e 2-pirazinoformamida isonicotinoil hidrazona (HPzAmIH, 5), sendo o composto HPAmIH (4) inédito. Análises de ponto de fusão, espectroscopia de infravermelho (IV), espectrometria de massas, ressonância magnética nuclear (RMN), análise elementar e termogravimetria confirmaram a obtenção e pureza das hidrazonas. Foi determinada ainda a estrutura de HPCIH (1) por difração de raios X de monocristal. Essas moléculas foram efetivas em inibir o crescimento de cepas de micobactérias Mycobacterium tuberculosis H37Rv (ATCC 27294) nas concentrações testadas, com exceção de HPzAmIH (5). As hidrazonas HAPIH (2) e HBPIH (3) foram os compostos orgânicos mais ativos (concentração inibitória mínima, CIM = 0,625 g/mL), apresentando atividade antimicobacteriana apenas duas vezes inferior à do fármaco isoniazida.Quanto à ação contra células tumorais, as hidrazonas HAPIH (2) e HBPIH (3) foram as mais potentes contra as linhagens OVCAR-8 (tumor de ovário - humano), HCT-116 (tumor de cólon - humano) e SF-295 (glioblastoma humano), com inibições de 34,98 a 98,63% do crescimento celular, na concentração de 5 g/mL, enquanto que a isoniazida não foi efetiva contra as linhagens estudadas. Para avaliar o efeito da coordenação a metais sobre a atividade farmacológica das hidrazonas, foram sintetizados os complexos de cobre(II) e gálio(III), sendo todos inéditos: [Cu(HPCIH)Cl2]∙H2O (6), [Cu(HAPIH)Cl2]∙H2O (7), [Cu2(HBPIH)2Cl2]Cl2∙4H2O(8), [Cu(HPAmIH)Cl2]∙H2O (9), [Cu(HPzAmIH)Cl2]∙H2O (10), [Ga(HPCIH)2](NO3)32H2O (11), [Ga(HAPIH)(APIH)](NO3)22H2O (12), [Ga(HPAmIH)(PAmIH)](NO3)22H2O(13) e [Ga(HPzAmIH)(PzAmIH)](NO3)2H2O (14). Os complexos foram caracterizados por espectroscopia de IV, análise elementar, condutivimetria, RMN e espectroscopia eletrônica. Em geral, os complexos também demonstraram ação contra M. tuberculosis, sendo que apenas para 6, 9, 10 e 14 foi verificada melhor atividade em relação às hidrazonas livres. Os complexos metálicos foram tanto quanto ou mais ativos contra as células tumorais OVCAR-8, HCT-116 e SF-295 do que as hidrazonas livres. Merecem destaque os complexos 79 e 12, que apresentaram inibição de crescimento celular de 72,2100%, na concentração de 5 g/mL. Os resultados demonstram portanto que em geral os compostos 114 são menos ativos do que a isoniazida contra M. tuberculosis, enquanto que a modificação química do fármaco, formando-se hidrazonas com posterior complexação cobre(II) e gálio(III) constituíram uma estratégia interessante na obtenção de compostos mais potentes contra células tumorais / In this work we describe the synthesis of isoniazide-derived hydrazones and their copper(II) and gallium(III) complexes candidates for drug prototypes to treat antituberculosis and cancer. Five hidrazone derivatives have been prepared in order to investigate the effect of chemical modification on the bioactivities of the drug isoniazid: 2-pyridinecarboxaldehyde isonicotinoyl hydrazone (HPCIH, 1), 2-acetylpyridine isonicotinoyl hydrazone (HAPIH, 2), 2-benzoylpyridine isonicotinoyl hydrazone (HBPIH, 3), 2-pyridineformamide isonicotinoyl hydrazone (HPAmIH, 4) and pyrazineformamide 2-isonicotinoyl hydrazone (HPzAmIH, 5), being HPAmIH (4) unpublished. Melting point, infrared spectroscopy (IR), mass spectrometry, nuclear magnetic resonance (NMR), elemental analysis and thermogravimetric analysis has confirmed the formation of hydrazones as well as its purity. All compounds have been effective in inhibiting the growth of Mycobacterium tuberculosis H37Rv (ATCC 27294) mycobacteria strains in the tested concentrations, except HPzAmIH (5). The hydrazones HAPIH (2) and HBPIH (3) have been the most active compounds (minimum inhibitory concentration, MIC = 0.625 g/mL), which have presented the antimycobacterial activity only two times lower than isoniazid drug. In relation to the action against tumor cells, the hydrazones HAPIH (2) and HBPIH (3) have been the most potent compounds against the cell lines OVCAR-8 (ovarian tumor - human), HCT-116 (colon tumor - human) and SF-295 (glioblastoma - human), with inhibitions from 34.98 to 98.63% of cellular growth at a concentration of 5 g/mL. Isoniazid, in turn, hasnt been effective against all cell lines studied. To evaluate the effect of coordinating the metal on the pharmacological activity of hydrazones, complexes of copper (II) and gallium (III) have been synthesized, being all novel compounds: [Cu(HPCIH)Cl2]∙H2O (6), [Cu(HAPIH)Cl2]∙H2O (7), [Cu2(HBPIH)2Cl2]Cl2∙4H2O(8), [Cu(HPAmIH)Cl2]∙H2O (9), [Cu(HPzAmIH)Cl2]∙H2O (10), [Ga(HPCIH)2](NO3)32H2O (11), [Ga(HAPIH)(APIH)](NO3)22H2O (12), [Ga(HPAmIH)(PAmIH)](NO3)22H2O (13) and [Ga(HPzAmIH)(PzAmIH)](NO3)2H2O (14).The complexes have been characterized by IR spectroscopy, NMR, elemental analysis, conductivimetry and electron spectroscopy. In general, these complexes have also shown action against M. tuberculosis, whereas only 6, 9, 10 and 14 have demonstrated better activity than the free hydrazones. The metal complexes have been equally or more active against human the cancer cell lines OVCAR-8, HCT-116 and SF-295 than the free hydrazones. The complexes 79 and 12 deserve to be highlighted, which have shown 72.2100% inhibition of cell growth in the 5 g/mL concentration. The results therefore demonstrate that in general compounds 114 are less active than isoniazid against M. tuberculosis, while chemical modification of the drug, forming hydrazones and subsequent complexation with the copper (II) and gallium(III) metal ions have been an interesting strategy to obtain compounds more potent against tumor cells

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / No presente trabalho é descrita a obtenção de hidrazonas derivadas de isoniazida e de seus complexos de cobre(II) e gálio(III) candidatos a protótipos de fármacos antituberculose e antitumoral. Para investigar o efeito da modificação química sobre as bioatividades do fármaco isoniazida, foram preparados cinco derivados hidrazônicos: 2-piridinocarboxaldeído isonicotinoil hidrazona (HPCIH, 1), 2-acetilpiridina isonicotinoil hidrazona (HAPIH, 2), 2-benzoilpiridina isonicotinoil hidrazona (HBPIH, 3), 2-piridinoformamida isonicotinoil hidrazona (HPAmIH, 4) e 2-pirazinoformamida isonicotinoil hidrazona (HPzAmIH, 5), sendo o composto HPAmIH (4) inédito. Análises de ponto de fusão, espectroscopia de infravermelho (IV), espectrometria de massas, ressonância magnética nuclear (RMN), análise elementar e termogravimetria confirmaram a obtenção e pureza das hidrazonas. Foi determinada ainda a estrutura de HPCIH (1) por difração de raios X de monocristal. Essas moléculas foram efetivas em inibir o crescimento de cepas de micobactérias Mycobacterium tuberculosis H37Rv (ATCC 27294) nas concentrações testadas, com exceção de HPzAmIH (5). As hidrazonas HAPIH (2) e HBPIH (3) foram os compostos orgânicos mais ativos (concentração inibitória mínima, CIM = 0,625 g/mL), apresentando atividade antimicobacteriana apenas duas vezes inferior à do fármaco isoniazida.Quanto à ação contra células tumorais, as hidrazonas HAPIH (2) e HBPIH (3) foram as mais potentes contra as linhagens OVCAR-8 (tumor de ovário - humano), HCT-116 (tumor de cólon - humano) e SF-295 (glioblastoma humano), com inibições de 34,98 a 98,63% do crescimento celular, na concentração de 5 g/mL, enquanto que a isoniazida não foi efetiva contra as linhagens estudadas. Para avaliar o efeito da coordenação a metais sobre a atividade farmacológica das hidrazonas, foram sintetizados os complexos de cobre(II) e gálio(III), sendo todos inéditos: [Cu(HPCIH)Cl2]∙H2O (6), [Cu(HAPIH)Cl2]∙H2O (7), [Cu2(HBPIH)2Cl2]Cl2∙4H2O(8), [Cu(HPAmIH)Cl2]∙H2O (9), [Cu(HPzAmIH)Cl2]∙H2O (10), [Ga(HPCIH)2](NO3)32H2O (11), [Ga(HAPIH)(APIH)](NO3)22H2O (12), [Ga(HPAmIH)(PAmIH)](NO3)22H2O(13) e [Ga(HPzAmIH)(PzAmIH)](NO3)2H2O (14). Os complexos foram caracterizados por espectroscopia de IV, análise elementar, condutivimetria, RMN e espectroscopia eletrônica. Em geral, os complexos também demonstraram ação contra M. tuberculosis, sendo que apenas para 6, 9, 10 e 14 foi verificada melhor atividade em relação às hidrazonas livres. Os complexos metálicos foram tanto quanto ou mais ativos contra as células tumorais OVCAR-8, HCT-116 e SF-295 do que as hidrazonas livres. Merecem destaque os complexos 79 e 12, que apresentaram inibição de crescimento celular de 72,2100%, na concentração de 5 g/mL. Os resultados demonstram portanto que em geral os compostos 114 são menos ativos do que a isoniazida contra M. tuberculosis, enquanto que a modificação química do fármaco, formando-se hidrazonas com posterior complexação cobre(II) e gálio(III) constituíram uma estratégia interessante na obtenção de compostos mais potentes contra células tumorais / In this work we describe the synthesis of isoniazide-derived hydrazones and their copper(II) and gallium(III) complexes candidates for drug prototypes to treat antituberculosis and cancer. Five hidrazone derivatives have been prepared in order to investigate the effect of chemical modification on the bioactivities of the drug isoniazid: 2-pyridinecarboxaldehyde isonicotinoyl hydrazone (HPCIH, 1), 2-acetylpyridine isonicotinoyl hydrazone (HAPIH, 2), 2-benzoylpyridine isonicotinoyl hydrazone (HBPIH, 3), 2-pyridineformamide isonicotinoyl hydrazone (HPAmIH, 4) and pyrazineformamide 2-isonicotinoyl hydrazone (HPzAmIH, 5), being HPAmIH (4) unpublished. Melting point, infrared spectroscopy (IR), mass spectrometry, nuclear magnetic resonance (NMR), elemental analysis and thermogravimetric analysis has confirmed the formation of hydrazones as well as its purity. All compounds have been effective in inhibiting the growth of Mycobacterium tuberculosis H37Rv (ATCC 27294) mycobacteria strains in the tested concentrations, except HPzAmIH (5). The hydrazones HAPIH (2) and HBPIH (3) have been the most active compounds (minimum inhibitory concentration, MIC = 0.625 g/mL), which have presented the antimycobacterial activity only two times lower than isoniazid drug. In relation to the action against tumor cells, the hydrazones HAPIH (2) and HBPIH (3) have been the most potent compounds against the cell lines OVCAR-8 (ovarian tumor - human), HCT-116 (colon tumor - human) and SF-295 (glioblastoma - human), with inhibitions from 34.98 to 98.63% of cellular growth at a concentration of 5 g/mL. Isoniazid, in turn, hasnt been effective against all cell lines studied. To evaluate the effect of coordinating the metal on the pharmacological activity of hydrazones, complexes of copper (II) and gallium (III) have been synthesized, being all novel compounds: [Cu(HPCIH)Cl2]∙H2O (6), [Cu(HAPIH)Cl2]∙H2O (7), [Cu2(HBPIH)2Cl2]Cl2∙4H2O(8), [Cu(HPAmIH)Cl2]∙H2O (9), [Cu(HPzAmIH)Cl2]∙H2O (10), [Ga(HPCIH)2](NO3)32H2O (11), [Ga(HAPIH)(APIH)](NO3)22H2O (12), [Ga(HPAmIH)(PAmIH)](NO3)22H2O (13) and [Ga(HPzAmIH)(PzAmIH)](NO3)2H2O (14).The complexes have been characterized by IR spectroscopy, NMR, elemental analysis, conductivimetry and electron spectroscopy. In general, these complexes have also shown action against M. tuberculosis, whereas only 6, 9, 10 and 14 have demonstrated better activity than the free hydrazones. The metal complexes have been equally or more active against human the cancer cell lines OVCAR-8, HCT-116 and SF-295 than the free hydrazones. The complexes 79 and 12 deserve to be highlighted, which have shown 72.2100% inhibition of cell growth in the 5 g/mL concentration. The results therefore demonstrate that in general compounds 114 are less active than isoniazid against M. tuberculosis, while chemical modification of the drug, forming hydrazones and subsequent complexation with the copper (II) and gallium(III) metal ions have been an interesting strategy to obtain compounds more potent against tumor cells